- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/107 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles with two aryl or substituted aryl radicals attached in positions 2 and 5
Patent holdings for IPC class C07D 271/107
Total number of patents in this class: 86
10-year publication summary
|
4
|
9
|
9
|
9
|
1
|
3
|
6
|
2
|
5
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3394 |
3 |
| Array BioPharma Inc. | 498 |
3 |
| Cedars-Sinai Medical Center | 1162 |
3 |
| Receptos LLC | 63 |
3 |
| Alphala Co., Ltd. | 18 |
3 |
| Merck Sharp & Dohme LLC | 3751 |
3 |
| LG Chem, Ltd. | 17635 |
2 |
| Semiconductor Energy Laboratory Co., Ltd. | 11428 |
2 |
| Beijing Aglaia Technology Development Co., Ltd. | 40 |
2 |
| Beijing Foreland Biopharma Co., Ltd. | 2 |
2 |
| BIAL - Portela & CA, S.A. | 222 |
2 |
| Crysoptix KK | 38 |
2 |
| Microbiotix, Inc. | 41 |
2 |
| The Penn State Research Foundation | 1527 |
2 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 292 |
2 |
| Sporos Biodiscovery, Inc. | 6 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Hoffmann-La Roche Inc. | 3439 |
1 |
| BASF SE | 20940 |
1 |
| The Regents of the University of California | 19961 |
1 |
| Other owners | 44 |